Neil Poulter

1.3k total citations
21 papers, 750 citations indexed

About

Neil Poulter is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Neil Poulter has authored 21 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Neil Poulter's work include Blood Pressure and Hypertension Studies (8 papers), Nutritional Studies and Diet (4 papers) and Diabetes Treatment and Management (4 papers). Neil Poulter is often cited by papers focused on Blood Pressure and Hypertension Studies (8 papers), Nutritional Studies and Diet (4 papers) and Diabetes Treatment and Management (4 papers). Neil Poulter collaborates with scholars based in United Kingdom, Australia and United States. Neil Poulter's co-authors include Mark Woodward, Sophia Zoungas, John Chalmers, Bryan Williams, Qiang Li, Stephen Harrap, Anushka Patel, Pavel Hamet, Michel Marre and Mark E. Cooper and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Neil Poulter

16 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil Poulter United Kingdom 9 342 260 111 94 87 21 750
Tomi-Pekka Tuomainen Finland 6 241 0.7× 334 1.3× 70 0.6× 90 1.0× 78 0.9× 7 755
Mary Mamakeesick Canada 15 232 0.7× 196 0.8× 114 1.0× 125 1.3× 159 1.8× 23 698
Martin Shipley United Kingdom 7 358 1.0× 267 1.0× 89 0.8× 125 1.3× 173 2.0× 12 786
Charles F. Shaefer United States 10 370 1.1× 132 0.5× 129 1.2× 130 1.4× 107 1.2× 18 702
Yamini S. Levitzky United States 8 303 0.9× 433 1.7× 132 1.2× 98 1.0× 143 1.6× 11 968
Ligita Ryliškytė Lithuania 14 193 0.6× 434 1.7× 95 0.9× 64 0.7× 119 1.4× 55 850
Zhenhua Xing China 15 234 0.7× 279 1.1× 157 1.4× 85 0.9× 123 1.4× 56 694
Amra Jujić Sweden 17 144 0.4× 403 1.6× 140 1.3× 140 1.5× 64 0.7× 61 793
Ahmet Karabulut Türkiye 18 330 1.0× 294 1.1× 243 2.2× 102 1.1× 281 3.2× 70 1.0k
Luis D’Marco Spain 18 312 0.9× 387 1.5× 288 2.6× 158 1.7× 124 1.4× 64 1.2k

Countries citing papers authored by Neil Poulter

Since Specialization
Citations

This map shows the geographic impact of Neil Poulter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Poulter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Poulter more than expected).

Fields of papers citing papers by Neil Poulter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Poulter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Poulter. The network helps show where Neil Poulter may publish in the future.

Co-authorship network of co-authors of Neil Poulter

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Poulter. A scholar is included among the top collaborators of Neil Poulter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Poulter. Neil Poulter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Tiffany, et al.. (2025). Community pharmacy-based hypertension screening: May Measurement Month 2023 in 3 Canadian provinces. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 158(2). 77–80.
2.
3.
Ohkuma, Toshiaki, Katie Harris, Mark Woodward, et al.. (2024). Intensive Glucose Lowering and Its Effects on Vascular Events and Death According to Age at Diagnosis and Duration of Diabetes: The ADVANCE Trial. Diabetes Care. 48(2). 279–284. 4 indexed citations
4.
Graham, Colin A., Joanna M. Prasher, Margarita Capel, et al.. (2024). Trends in hypertension prevalence and control in England over the last 3 decades: Health Survey of England 1994-2019. European Heart Journal. 45(Supplement_1).
5.
Graham, Cynthia, Margarita Capel, Joanna M. Prasher, et al.. (2024). Nationwide trends in blood pressure control among those with and without diabetes in England over last 2 decades: Health Survey of England 2003-2019. European Heart Journal. 45(Supplement_1). 1 indexed citations
6.
7.
Schlaich, Markus P., et al.. (2023). PS-P04-7: ALERTING REACTION OF BLOOD PRESSURE AND AGE: MAY MEASUREMENT MONTH 2019. Journal of Hypertension. 41(Suppl 1). e247–e248. 1 indexed citations
8.
9.
Wang, Nelson, Katie Harris, Pavel Hamet, et al.. (2022). Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With Diabetes. Journal of the American College of Cardiology. 80(12). 1147–1155. 24 indexed citations
10.
Anand, Shuchi, Roopa Shivashankar, Dimple Kondal, et al.. (2020). Potassium Intake in India: Opportunity for Mitigating Risks of High-Sodium Diets. American Journal of Preventive Medicine. 58(2). 302–312. 6 indexed citations
11.
Poulter, Neil, Aisha Anjum, Mary Cross, et al.. (2016). LBOS 01-01A COMPARISON OF THE IMPACT OF MORNING OR NIGHT DELIVERY OF ANTIHYPERTENSIVE AGENTS ON 24 HOUR ABPM LEVELS. Journal of Hypertension. 34(Supplement 1). e547–e547. 1 indexed citations
12.
Zoungas, Sophia, Mark Woodward, Qiang Li, et al.. (2014). Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 57(12). 2465–2474. 367 indexed citations
13.
Hata, Jun, Hisatomi Arima, Sophia Zoungas, et al.. (2013). Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial. PLoS ONE. 8(2). e55807–e55807. 53 indexed citations
14.
15.
Manisty, Charlotte, Jamil Mayet, Robyn J. Tapp, et al.. (2010). Wave Reflection Predicts Cardiovascular Events in Hypertensive Individuals Independent of Blood Pressure and Other Cardiovascular Risk Factors. Journal of the American College of Cardiology. 56(1). 24–30. 82 indexed citations
16.
Primatesta, Paola, et al.. (1999). Blood lead and blood pressure: evidence from the Health Survey for England 1995. Journal of Human Hypertension. 13(2). 123–128. 17 indexed citations
17.
Primatesta, Paola, et al.. (1997). 6.2 Blood lead and blood pressure revisited. Journal of Hypertension. 15(12). 1547–1548. 1 indexed citations
18.
Kornitzer, Marcel, et al.. (1993). Psychosocial factors in perspective. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 231–250. 1 indexed citations
19.
Henney, Adriano, M Adiseshiah, Neil Poulter, et al.. (1993). Abdominal aortic aneurysm. The Lancet. 341(8839). 215–220. 46 indexed citations
20.
Poulter, Neil, Simon Thom, & Peter Sever. (1991). First line treatment in hypertension. BMJ. 302(6768). 116–116. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomi-Pekka Tuomainen Breakdown of academic impact, for papers by Mary Mamakeesick Breakdown of academic impact, for papers by Martin Shipley Breakdown of academic impact, for papers by Charles F. Shaefer Breakdown of academic impact, for papers by Yamini S. Levitzky Breakdown of academic impact, for papers by Ligita Ryliškytė Breakdown of academic impact, for papers by Zhenhua Xing Breakdown of academic impact, for papers by Amra Jujić Breakdown of academic impact, for papers by Ahmet Karabulut Breakdown of academic impact, for papers by Luis D’Marco
Rankless by CCL
2026